Figure 5.
Forest plot of meta-analysis of adverse events for vedolizumab vs. placebo: A – any adverse event, B – serious adverse events, C – serious infection (ITT analysis)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.